Opioid Treatment Program
Our holistic, person-centered quality framework of standards reflects leadership in the field internationally through the promotion and advancement of medication-assisted treatment (MAT) for persons diagnosed with opioid use disorder.
Opioid Treatment Programs (OTPs) provide medication-assisted treatment for persons diagnosed with opioid use disorder using any of three FDA-approved medications (methadone, buprenorphine, and naltrexone).
OTPs dispense medication and are certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT). To be certified by SAMHSA, an OTP must be accredited by a CSAT-approved accreditor such as CARF. We accredit the majority of OTPs in the United States.
What we accredit
Standards for the following types of programs/services are in the Opioid Treatment Program (OTP) Standards Manual:
OTPs must select one core program:
OTPs offer a comprehensive continuum of services can apply supplementary standards for:
Specific population designations
The following may be added to a program:
Medicare reimbursements for OTPs
The Support Act of 2018 included a requirement that OTP services be reimbursed through the Medicare program. View the Medicare billing and payment fact sheet. More information is available on the Centers for Medicare & Medicaid Services (CMS) website.
Opioid Response Network
Get to know the standards
We are your partner for quality and success
We’re here to help!
No matter where you are in your accreditation journey, we are here to answer your questions and provide assistance.
The Managing Director
Emily Hosea has experience in a variety of settings that focused on substance use disorders, mental health, and crisis intervention.